Synergistic proliferation induced by insulin and glycated serum albumin in rat vascular smooth muscle cells

( views:84, downloads:0 )
HE Rong()
QU Ai-Juan()
MAO Jie-Ming()
WANG Xian()
SUN Wei()
Journal Title:
Volume 59, Issue 01, 2007
Key Word:
diabetes;insulin;advanced glycation end products;glycated serum albumin;vascular smooth muscle cells

Abstract: Hyperglycemia, advanced glycation end products (AGEs), hyperinsulinemia and dyslipidemia may play roles in the development of diabetes-associated atherosclerosis and post-angioplasty restenosis. Clinically, their effects seem to be synergic.However, few studies have focused on the synergistic action of these factors. In the present study, we investigated wheth er glycated serum albumin (GSA) has a synergistic effect with insulin on the proliferation of vascular smooth muscle cells (VSMCs). VSMCs were isolated from rat thoracic aortas and cultured in fetal bovine serum (FBS)-free medium for 24 h, then exposed to GSA, insulin or GSA + insulin for 48 h with or without pretreatment of mitogen-activated protein kinase (MAPK) inhibitors or the antioxidant N-acetylcysteine (NAC). Cell growth rate was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay or cell counting. The changes of phosphorylated-p38 MAPK and phosphorylated-C-Jun N-terminal kinase 1/2 (JNK1/2) were measured by Western blot analysis. The results showed that only p38 MAPK, but not JNK was activated by GSA and insulin co-incubation. VSMC proliferation was increased by insulin (10-1000 nmol/L) or GSA (10, 100 μg/mL). Co-incubation of insulin (100 nmol/L) and GSA (100 μg/mL) caused a more potent increase in VSMC proliferation than insulin or GSA incubation alone. P38 MAPK inhibitor, SB203580,as well as NAC, could inhibit the VSMC proliferation induced by co-incubation of GSA and insulin. The results show that insulin enhances GSA-induced VSMC proliferation, which may be mediated through a reactive oxygen species (ROS)-p38 MAPK pathway.The synergism of AGEs and insulin may play a detrimental role in the pathogenesis of diabetic atherosclerosis and post-angioplasty restenosis.

  • [1]Pyorala K,Laasko M,Uusitupa M.Diabetes and atherosclerosis:an epidemiologic view.Diabetes Metab Rev 1987; 3 (2):463-524.
  • [2]Haffner SM,Lehto S,Ronnemaa T,Pyorala K,Laakso M.Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior history of myocardial infarction.N Engl J Med 1998; 339(4):229-234.
  • [3]Carrozza JP Jr,Kuntz RE,Fishman RF,Baim DS.Restenosis after arterial injury caused by coronay stenting in patients with diabetes.Ann Intern Med 1993; 118(5):344-349.
  • [4]Aronoson D,Bloomgarden Z,Rayfield EJ.Potential mechanisms promoting restenosis in diabetic patients.J Am Coll Cardiol 1996; 27(3):528-535.
  • [5]Welborn TA,Wearne K.Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.Diabetes Care 1979; 2(2):154-160.
  • [6]Ouyang P (欧阳平),Peng WL,Xu DL,Lai WY,Xu AL.Green tea polyphenols inhibit advanced glycation end product-induced rat vascular smooth muscle cell proliferation.J First Mil Med Univ (第一军医大学学报) 2004; 24(9):247-251 (Chinese,English abstract).
  • [7]Zhou Z,Wang K,Penn MS,Marso SP,Lauer MA,Forudi F,Zhou X,Qu W,Lu Y,Stern DM,Schmidt AM,Lincoff AM,Topol EJ.Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.Circulation 2003; 107(17):2238-2243.
  • [8]Zhu DL (朱鼎良),Gogusev J,Marche P.Macrophage colonystimulating factor production and c-fms expression in cultured rat aortic vascular smooth muscle cells.Acta Physiol Sin (生理学报) 1999; 51(2):181-186.(Chinese,English abstract)
  • [9]Chiba K,Kawakami K,Tohyama K.Simultaneous evaluation of cell viability by neutral red,MTT and crystal violet staining assays of the same cells.Toxicol In Vitro 1998; 12(3):251-258.
  • [10]Stitt AW,He C,Friedman S,Scher L,Rossi P,Ong L,Founds H,Li YM,Bucala R,Vlassara H.Elevated AGE modified ApoB in sera of euglycaemic,normolipidaemic patients with atherosclerosis:relation to tissue AGE.Mol Med 1997; 3(9):617-627.
  • [11]Tan KCB,Chow WS,Tam S,Bucala R,Betteridge J.Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.Diabetes Care 2004; 27(1):223-228.
  • [12]Schiel R,Franke S,Appel T,Voigt U,Ross IS,Kientsch-Engel R,Stein G,Müller UA.Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN).J Diabetes Complications 2003; 17(2):90-97.
  • [13]Shimoike T,Inoguchi T,Umeda F,Nawata H,Katsumi K,Ochi H.The meaning of serum levels of advanced glycation products in diabetic nephropathy.Metabolism 2000; 49(8):1030-1035.
  • [14]Sakaguchi T,Yan SF,Yan SD,Belov D,Rong LL,Sousa M,Andrassy M,Marso AP,Duda S,Arnold B,Liliensiek B,Nawroth PP,Stern DM,Schmidt AM,Naka Y.Central role of RAGEs-dependent neointimal expansion in arterial restenosis.J Clin Invest 2003; 111(7):959-972.
  • [15]Lander HM,Tauras JM,Ogister JS,Hori Osamu,Moss RA,Schmidt AM.Activation of the receptor for advanced glycation end products triggers a p21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.J Biol Chem 1997; 272(28):17810-17814.
  • [16]Bierhaus A,Chevion S,Chevion M,Hofmann M,Quehenberger P,Tritschler H,Wahl P,Ziegler R,Muller M,Nawroth PP.Advanced glycation end products induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells.Diabetes 1997; 46(9):1481-1490.
  • [17]Wautier MP,Chappey O,Corda S,Stern DM,Schmidt AM,Wautier JL.Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.Am J Physiol Endocrinol Metab 2001; 280(5):E685-E694.
  • [18]Peiro C,Matesanz N,Nevado J,Lafuente N,Cercas E,Azcutia V,Vallejo S,Rodriguez-Manas L,Sanchez-Ferrer CF.Glycosylated human oxyhaemoglobin activates nuclear factorκB and activator protein-1 in cultured human aortic smooth muscle.Br J Pharmacol 2003; 140(4):681-690.
  • [19]Zhang LF,Zalewski A,Liu Y,Mazurek T,Cowan S,Martin JL,Hofmann SM,Vlassara H,Shi Y.Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries.Circulation 2003; 108(4):472-478.
  • [20]Ehlermann P,Eggers K,Bierhaus A,Most P,Weichenhan D,Greten J,Nawroth PP,Katus HA,Remppis A.Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.Cardiovasc Diabetol 2006; 5:6-15.
  • [21]Yeh CH,Sturgis L,Haidacher J,Zhang XN,Sherwood SJ,Bjercke RJ,Juhasz O,Crow MT,Tilton RG,Denner L.Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.Diabetes 2001; 50(6):1495-1504.
  • [22]Sundaresan M,Yu ZX,Ferrans VJ,Irani K,Finkel T Requirement for generation of H2O2 for platelet-derived growth factor signal transduction.Science 1995; 270(5234):296-299.
  • [23]Viedt C,Soto U,Krieger-Brauer HI,Fei J,Elsing C,Kubler W,Kreuzer J.Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin Ⅱ:involvement of p22phox and reactive oxygen species.Arterioscler Thromb Vasc Biol2000; 20(4):940-948.
  • [24]Han MJ,Kim BY,Yoon SO,Chung AS.Cell proliferation induced by reactive oxygen species is mediated via mitogenactivated protein kinase in Chinese hamster lung fibroblast (V79) cells.Mol Cells 2003; 15(1):94-101.
  • [25]Hattori Y,Suzuki M,Hattori S,Kasai K.Vascular smooth muscle cell activation by glycated albumin.Hypertension 2002; 39(1):22-28.
  • [26]Seki N,Hashimoto N,Sano H,Horiuchi S,Yagui K,Makino H,Saito Y.Mechanisms involved in the stimulatory effect of ad vanced glycation end products on growth of rat aortic smooth muscle cells.Metabolism 2003; 52(12):1558-1563.
  • [27]Dan Q,Wong R,Chung SK,Chung SS,Lam KS.Interaction between the polyol pathway and non-enzymatic glycation on aortic smooth muscle cell migration and monocyte adhesion.Life Sci 2004; 76(4):445-459.
  • [28]Takagi T,Youshifa K,Akasaka T,Kaji S,Kavamoto T,Honda Y,Yamamuro A,Hozumi T,Morioka S.Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients:a serial intravascular ultrasound study.J Am Coll Cardiol2000; 36(3):731-738.
  • [29]Golovchenko I,Goalstone ML,Watson P,Brownlee M,Draznin B.Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin Ⅱ,hyperglycemia,and advanced glycosylation end products in vascular smooth muscle cells.Circ Res 2000; 87(9):746-752.
  • [30]Treins C,Giorgetti-Peraldi S,Murdaca J,Van Obberghen E.Regulation of vascular endothelial growth factor expression by advanced glycation end products.J Biol Chem 2001; 276(47):43836-43841.
  • [31]De Oliveira C,Colette C,Monnier L,Descomps B,Pares-Herbute N.Insulin alters nuclear factor-κB and peroxisome proliferatorsactivated receptor-γ protein expression induced by glycated bovine serum albumin in vascular smooth muscle cells.J Lab Clin Med 2005; 145(3):144-150.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615